We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.21B
AUM Growth
+$110M
Cap. Flow
-$79.3M
Cap. Flow %
-3.59%
Top 10 Hldgs %
22.7%
Holding
3,121
New
66
Increased
341
Reduced
717
Closed
30

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$3.73M
2
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$3.01M
3
COP icon
ConocoPhillips
COP
+$2.6M
4
NOW icon
ServiceNow
NOW
+$1.95M
5
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.95M

Top Sells

Rank Stock Value
1
MDY icon
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
+$6.14M
2
MSFT icon
Microsoft
MSFT
+$4.3M
3
VOO icon
Vanguard S&P 500 ETF
VOO
+$3.96M
4
TER icon
Teradyne
TER
+$3.85M
5
ETSY icon
Etsy
ETSY
+$3.81M

Sector Composition

Rank Sector Weight
1 Technology 17.76%
2 Consumer Discretionary 10.46%
3 Healthcare 9.6%
4 Financials 9.53%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THFF icon
2026
First Financial Corp
THFF
$975M
$36K ﹤0.01%
1,151
– –
WMK icon
2027
Weis Markets
WMK
$1.77B
$36K ﹤0.01%
747
– –
WSBF icon
2028
Waterstone Financial
WSBF
$385M
$36K ﹤0.01%
2,330
– –
TECX
2029
Tectonic Therapeutic
TECX
$664M
$36K ﹤0.01%
227
– –
CFB
2030
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$36K ﹤0.01%
4,100
– –
CDMO
2031
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$36K ﹤0.01%
4,695
– –
CBAY
2032
DELISTED
Cymabay Therapeutics
CBAY
$36K ﹤0.01%
4,918
– –
BZH icon
2033
Beazer Homes USA
BZH
$874M
$35K ﹤0.01%
2,686
– –
CYH icon
2034
Community Health Systems
CYH
$419M
$35K ﹤0.01%
8,353
– –
HVT icon
2035
Haverty Furniture Companies
HVT
$450M
$35K ﹤0.01%
1,689
– –
HWKN icon
2036
Hawkins
HWKN
$2.67B
$35K ﹤0.01%
1,498
– –
KNSA icon
2037
Kiniksa Pharmaceuticals
KNSA
$6.07B
$35K ﹤0.01%
2,278
+598
+36% +$11.2K
KOS icon
2038
Kosmos Energy
KOS
$1.51B
$35K ﹤0.01%
35,615
– –
QCRH icon
2039
QCR Holdings
QCRH
$1.75B
$35K ﹤0.01%
1,290
– –
REPL icon
2040
Replimune Group
REPL
$1.42B
$35K ﹤0.01%
1,521
– –
SNDX icon
2041
Syndax Pharmaceuticals
SNDX
$1.7B
$35K ﹤0.01%
2,380
– –
UA icon
2042
Under Armour Class C
UA
$2.25B
$35K ﹤0.01%
3,510
– –
UVE icon
2043
Universal Insurance Holdings
UVE
$1.18B
$35K ﹤0.01%
2,530
– –
VITL icon
2044
Vital Farms
VITL
$498M
$35K ﹤0.01%
+874
New +$33K
TPC
2045
Tutor Perini Cor
TPC
$4.98B
$35K ﹤0.01%
3,186
– –
NWLI
2046
DELISTED
National Western Life Group, Inc. Class A
NWLI
$35K ﹤0.01%
193
– –
ECOM
2047
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$35K ﹤0.01%
2,410
– –
MSGN
2048
DELISTED
MSG Networks Inc.
MSGN
$35K ﹤0.01%
3,693
– –
CLCT
2049
DELISTED
Collectors Universe
CLCT
$35K ﹤0.01%
706
– –
ASIX icon
2050
AdvanSix
ASIX
$446M
$34K ﹤0.01%
2,631
– –
80 81
82
83 84

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return

Ameritas Investment Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Ameritas Investment Partners held 3,121 positions worth $2.21B, up 5.2% from $2.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ameritas Investment Partners withdrew a net $79.3M in Q3 2020, closing 30 positions and reducing 717 holdings. Its most notable exit was Caesars Entertainment Corporation, an estimated $1.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Ameritas Investment Partners opened a new position in Jazz Pharmaceuticals worth $2.24M.

  • Ameritas Investment Partners's largest Q3 2020 buy was Jazz Pharmaceuticals: 15,701 shares worth $2.24M.
  • Ameritas Investment Partners added most to Invesco QQQ Trust in Q3 2020, an estimated $3.73M increase.
  • Ameritas Investment Partners's biggest Q3 2020 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $6.14M.
  • Ameritas Investment Partners fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $1.97M.
  • Ameritas Investment Partners's ten largest holdings make up 23% of its $2.21B portfolio in Q3 2020.
  • Ameritas Investment Partners opened 66 new positions and closed 30 in Q3 2020.
  • Ameritas Investment Partners's portfolio value rose 5.2% quarter-over-quarter to $2.21B.

Based on Ameritas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.